Novo Nordisk plans $6 billion investment to expand in Denmark
HQ Team November 10, 2023: Novo Nordisk plans to invest 42 million Danish kroner ($6 billion) in Denmark to create new capacities for.
Drugs
Health
Pharma
Drugs
Health
Pharma
Injecting drugs or inhaling them may up chances of addiction: NIH
HQ Team November 10, 2023: A drug taken intravenously or inhaled proved to be more addictive as it enters the human brain more.
Drugs
Health
Pharma
Valneva’s chikungunya jab gets FDA nod, first such for disease
HQ Team November 10, 2023: Valneva SE, a French vaccine maker, has got USFDA approval for its chikungunya vaccine, Ixchiq, to treat individuals.
Drugs
Health
Pharma
US, UK regulators give green light to Eli Lilly’s weight-loss treatment
HQ Team November 9, 2023: Eli Lilly’s weight-loss injection Zepbound, to be taken along as a supplement with diet and exercise, got the.
Drugs
Health
Pharma
Chimpanzees use high-ground reconnaissance to track rival groups
Chimpanzees spy on rival groups and confront them when there is a reduced risk, a study finds.
Drugs
Health
Medical
Newborn syphilis cases rise ten-fold in 2022 in a decade in US: CDC data
More than 3,700 babies in the US were born with syphilis in 2022 — ten times the number in 2012 — and people.
Drugs
Health
Pharma
Globally, 7.5 million people got tuberculosis last year: WHO report
Last year about 7.5 million people had tuberculosis (TB), the world’s second-most infectious killer, and multi-drug resistant form of the disease remains a.
Health
Medical
Pharma
Otsuka Medical gets USFDA nod for treatment of hypertension
Otsuka Medical Devices Co., announced its treatment for hypertension has got approval from the US Food and Drug Administration.
Health
Medical
Pharma
J&J to file USFDA request to start trials for surgical robots
Johnson & Johnson will apply with the USFDA to start clinical trials in the second half of 2024 for its robotic surgical system.
Drugs
Health
Pharma
Abcam shareholders approve Danaher Corp acquisition for $5.7 billion
HQ Team November 7, 2023: Shareholders of Abcam Plc., a UK-based manufacturer and supplier of antibodies and reagents used for medical research, have.